Intellego Technologies publicerade idag den 19 augusti 2021 sin delårsrapport för andra kvartalet 2021.
Redeye comments on Scandion’s Q2‘21 report, following an eventful quarter.
Redeye maintains our view of Annexin Pharmaceuticals and Base case of SEK 4 following the company’s ...
Carasent reported a stable quarter with good customer intake and clear signs of scalability.
Q2 EBIT of SEK 43m, -30% vs. ABGSCe, -20% vs. cons.
Nettoomsättningen sjönk till 0,4 mkr (1,5 mkr) vilket var under vår förväntan om 1,5 mkr.
Redeye leaves a comment on Acarix following the release of its Q2 report.
Redeye provides its take on the Q2 report where we note an encouraging engagement among clinics, tho...
There are no big surprises in the Q2’21 financials of Asarina Pharma.
Redeye states that while sales came in lower than expectations, the company continues to impress on ...
Redeye comments on Azelio’s largest order to date, corresponding to 20 TES.
The lead project Orviglance (also called Mangoral, an improved contrast agent addressing liver metastases) is slightly delayed by up to 6m d...
Redeye remains positive to Fortnox following a Q2 report matching our expectations, with record-high...
Redeye first comments on Dignitana's Q2 report. The sales development continues to be strong with a ...
Omsättningen i Q2'21 uppgick till EUR 8,8m vs våra estimat om 8,6m.
Redeye states that while numbers were slightly below our expectations, we still argue that the repor...
Beijer Group posted a record order intake in Q2’21 of more than half a billion SEK.
Redeye was really surprised to see the weak Q2 numbers showing significantly lower revenues and nega...
Redeye highlights that Calliditas continue to progress with the lead candidate Nefecon and the compa...
We expect Sparekassen Kronjylland to continue to benefit from the current sector tailwinds – a strong economic recovery and high activity le...
Nettoomsättningen i Q2'21 uppgick till 480 mkr vs våra estimat om 418 mkr.
Redeye comments on OssDsign’s Q2 report and emphasizes that activities during and after the quarter ...
Redeye views the Q2 report, with record sales and a strong pipeline, as a strong sign of the company progressing according to plan.
Due to some delays and changes the production guidance for 2021 was lowered to around 1,500 oz (prev...
Balco’s Q2 report showed a clear pick-up in order intake, although sales and earnings are still belo...
Cantargia reported its Q2 numbers this morning with an operating loss of SEK -86.
Q2 adj. EBIT SEK 71m, +5% vs. ABGSCe Encouraging recovery in transaction-based sales Expect positive...
Idag offentliggjorde Ecoclime sin delårsrapport för andra kvartalet 2021.
